EFFECTS OF INTENSIVE BLOOD PRESSURE CONTROL IN PATIENTS WITH EVIDENT CARDIOVASCULAR DISEASE

被引：0
|
作者：
Terentes-Printzios, Dimitrios [1 ]
Viachopoulos, Charalambos [1 ]
Aznaourids, Konstantinos [1 ]
Ioakeimidis, Nikolaos [1 ]
Xaplanteris, Panagiotis [1 ]
Lazaros, George [1 ]
Tousoulis, Dimitris [1 ]
机构：
[1] Hippokrateion Hosp, Athens Med Sch, Cardiol Dept 1, Athens, Greece
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(18)32455-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A1914
引用
收藏
页码：1914 / 1914
页数：1
相关论文
共 50 条
  • [31] The effects of protein intake on blood pressure and cardiovascular disease
    Appel, LJ
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (01) : 55 - 59
  • [32] Tight Versus Standard Blood Pressure Control in Patients With Hypertension With and Without Cardiovascular Disease
    Reboldi, Gianpaolo
    Angeli, Fabio
    de Simone, Giovanni
    Staessen, Jan A.
    Verdecchia, Paolo
    HYPERTENSION, 2014, 63 (03) : 475 - 482
  • [33] Intensive versus Standard Blood Pressure Control in Patients With Peripheral Artery Disease: The Systolic Blood Pressure Intervention Trial (SPRINT)
    Frary, Johanna
    Byrne, Christina
    Vaduganathan, Muthiah
    Biering-Srensen, Tor
    Olsen, Michael H.
    Bhatt, Deepak L.
    Pareek, Manan
    CIRCULATION, 2020, 142
  • [34] Intensive blood pressure control appears to be effective and safe in patients with peripheral artery disease: the Systolic Blood Pressure Intervention Trial
    Frary, Johanna Maria Christina
    Pareek, Manan
    Byrne, Christina
    Vaduganathan, Muthiah
    Biering-Sorensen, Tor
    Rujic, Dragana
    Kragholm, Kristian Hay
    Olesen, Thomas Bastholm
    Olsen, Michael Hecht
    Bhatt, Deepak L.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E38 - E40
  • [35] Blood Pressure Targets for Patients with Hypertension and Cardiovascular Disease
    Smith, Dustin K.
    Seales, Paul
    Seales, Sajeewane
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (05) : 276 - 277
  • [36] Genetic Predictors of Cardiovascular Outcomes during Intensive Blood Pressure Control in ACCORD
    Shah, Hetal S.
    Morieri, Mario L.
    Gao, He
    Skupien, Jan
    Marvel, Skylar
    Marcovina, Santica M.
    Sigal, Ronald J.
    Gerstein, Hertzel C.
    Wagner, Michael J.
    Motsinger-Reif, Alison A.
    Buse, John B.
    Kraft, Peter
    Mychaleckyj, Josyf C.
    Doria, Alessandro
    DIABETES, 2017, 66 : A3 - A3
  • [37] Blood pressure control status and effects of pravastatin on cardiovascular events occurrence in patients with dyslipidaemia
    Kushiro, T.
    Mizuno, K.
    Nakaya, N.
    Ohashi, Y.
    Teramoto, T.
    Yokoyama, S.
    Kakinoki, S.
    Nakamura, H.
    JOURNAL OF HUMAN HYPERTENSION, 2012, 26 (06) : 388 - 395
  • [38] Blood pressure control status and effects of pravastatin on cardiovascular events occurrence in patients with dyslipidaemia
    T Kushiro
    K Mizuno
    N Nakaya
    Y Ohashi
    T Teramoto
    S Yokoyama
    S Kakinoki
    H Nakamura
    Journal of Human Hypertension, 2012, 26 : 388 - 395
  • [39] A meta-analysis on standard and intensive blood pressure control in patients with chronic kidney disease
    Shiu, L. A.
    Diansuy, N. N.
    Ramirez-Ragasa, R. M.
    Pestano, N. S.
    Punzalan, F. E.
    Tumanan-Mendoza, B.
    EUROPEAN HEART JOURNAL, 2017, 38 : 851 - 851
  • [40] Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial
    O'Connor, P. J.
    Ismail-Beigi, F.
    Craven, T. E.
    Karl, D. M.
    Calles-Escandon, J.
    Hramiak, I.
    Genuth, S.
    Cushman, W. C.
    Gerstein, H. C.
    Probstfield, J. L.
    Katz, L.
    Schubart, U.
    DIABETOLOGIA, 2011, 54 : S23 - S24
12345